ASX - By Stock
|
4DX |
Re:
Ann: Market update on recent developments
|
|
LF916227
|
32 |
13K |
1 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
32
|
13K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs research agreement with West Los Angeles VA
|
|
LF916227
|
38 |
13K |
2 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
38
|
13K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
LF916227
|
841 |
392K |
13 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
841
|
392K
|
13
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs research agreement with West Los Angeles VA
|
|
LF916227
|
38 |
13K |
5 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
38
|
13K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs research agreement with West Los Angeles VA
|
|
LF916227
|
38 |
13K |
1 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
38
|
13K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical gains US CMS reimbursement for CT LVAS
|
|
LF916227
|
27 |
11K |
3 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
27
|
11K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs research agreement with West Los Angeles VA
|
|
LF916227
|
38 |
13K |
6 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
38
|
13K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
LF916227
|
841 |
392K |
17 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
841
|
392K
|
17
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2024
|
|
LF916227
|
24 |
9.5K |
19 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
24
|
9.5K
|
19
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
3.0K |
1.3M |
8 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
3.0K
|
1.3M
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
3.0K |
1.3M |
18 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
3.0K
|
1.3M
|
18
|
|
ASX - By Stock
|
IPG |
Re:
IPG price action
|
|
LF916227
|
130 |
65K |
6 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
130
|
65K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
3.0K |
1.3M |
27 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
3.0K
|
1.3M
|
27
|
|
ASX - By Stock
|
IPG |
HY24 Earnings
|
|
LF916227
|
0 |
299 |
0 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
0
|
299
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
LF916227
|
120 |
47K |
5 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
120
|
47K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
LF916227
|
120 |
47K |
12 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
120
|
47K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
LF916227
|
120 |
47K |
1 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
120
|
47K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
LF916227
|
120 |
47K |
10 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
120
|
47K
|
10
|
|
ASX - By Stock
|
IPG |
Re:
Ann: Trading Halt
|
|
LF916227
|
47 |
13K |
2 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
47
|
13K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical and Philips sign Memorandum of Understanding
|
|
LF916227
|
70 |
23K |
15 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
70
|
23K
|
15
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical and Philips sign Memorandum of Understanding
|
|
LF916227
|
70 |
23K |
9 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
70
|
23K
|
9
|
|
ASX - By Stock
|
IPG |
Re:
Ann: Trading Halt
|
|
LF916227
|
47 |
13K |
3 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
47
|
13K
|
3
|
|
ASX - By Stock
|
IPG |
Re:
Ann: Trading Halt
|
|
LF916227
|
47 |
13K |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
47
|
13K
|
2
|
|
ASX - By Stock
|
IPG |
Re:
Ann: Trading Halt
|
|
LF916227
|
47 |
13K |
4 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
47
|
13K
|
4
|
|
ASX - By Stock
|
IPG |
Re:
Ann: Trading Halt
|
|
LF916227
|
47 |
13K |
1 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
47
|
13K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
LF916227
|
153 |
51K |
1 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
153
|
51K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
LF916227
|
153 |
51K |
1 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
153
|
51K
|
1
|
|
ASX - By Stock
|
IPG |
Re:
Downward Spiral
|
|
LF916227
|
21 |
9.0K |
0 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
21
|
9.0K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
LF916227
|
153 |
51K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
153
|
51K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical receives U.S. FDA clearance for CT LVAS
|
|
LF916227
|
38 |
18K |
18 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
38
|
18K
|
18
|
|
ASX - By Stock
|
4DX |
Re:
Ann: U.S. CMS Approves Reimbursement for 4DMedical
|
|
LF916227
|
150 |
71K |
6 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
150
|
71K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Ann: U.S. CMS Approves Reimbursement for 4DMedical
|
|
LF916227
|
150 |
71K |
18 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
150
|
71K
|
18
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
3.0K |
1.3M |
4 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
3.0K
|
1.3M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical enters contract with Integral Diagnostics
|
|
LF916227
|
11 |
4.4K |
10 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
11
|
4.4K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical enters contract with Integral Diagnostics
|
|
LF916227
|
11 |
4.4K |
16 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
11
|
4.4K
|
16
|
|
ASX - By Stock
|
IPG |
Re:
Downward Spiral
|
|
LF916227
|
21 |
9.0K |
3 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
21
|
9.0K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: FY2023 Full Year Results
|
|
LF916227
|
52 |
17K |
2 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
52
|
17K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: FY2023 Full Year Results
|
|
LF916227
|
52 |
17K |
6 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
52
|
17K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Ann: FY2023 Full Year Results
|
|
LF916227
|
52 |
17K |
2 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
52
|
17K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
LF916227
|
3.0K |
1.3M |
15 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
3.0K
|
1.3M
|
15
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2023
|
|
LF916227
|
29 |
13K |
11 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
29
|
13K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2023
|
|
LF916227
|
29 |
13K |
2 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
29
|
13K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 44Medical unveils VQ product at premier US lung conference
|
|
LF916227
|
52 |
18K |
3 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
52
|
18K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 44Medical unveils VQ product at premier US lung conference
|
|
LF916227
|
52 |
18K |
3 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
52
|
18K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 44Medical unveils VQ product at premier US lung conference
|
|
LF916227
|
52 |
18K |
10 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
52
|
18K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 44Medical unveils VQ product at premier US lung conference
|
|
LF916227
|
52 |
18K |
8 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
52
|
18K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 44Medical unveils VQ product at premier US lung conference
|
|
LF916227
|
52 |
18K |
4 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
52
|
18K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical wins commercial pilot with US Dept of Defense
|
|
LF916227
|
52 |
21K |
3 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
52
|
21K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical wins commercial pilot with US Dept of Defense
|
|
LF916227
|
52 |
21K |
7 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
52
|
21K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical wins commercial pilot with US Dept of Defense
|
|
LF916227
|
52 |
21K |
14 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
52
|
21K
|
14
|
|